4th Quarter - Report

ARNOLD & PORTER KAYE SCHOLER LLP for ADAPTIVE BIOTECHNOLOGIES

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2021 Commerce-Justice-Science Appropriations regarding the Eliminating Kickbacks in Recovery Act of 2018.

LobbyistCovered position, as disclosed
KRISTINE BLACKWOOD —
CASEY BROUHARD —
CJ MAHLER —
PARI MODY —
EUGENIA PIERSON —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Issues related to lab analysis and review of diagnostics and lab developed tests, including the VALID Act of 2020 (H.R. 6102/S. 3404), Eliminating Kickbacks in Recovery Act of 2018, and 21st Century Cures 2.0 Concept Paper.

LobbyistCovered position, as disclosed
KRISTINE BLACKWOOD —
CASEY BROUHARD —
CJ MAHLER —
PARI MODY —
EUGENIA PIERSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6102 (116th), S. 3404 (116th)

Medicare/Medicaid MMM

Issues related to lab analysis and review of diagnostics and lab developed tests, including VALID Act of 2020 (H.R. 6102/S. 3404), Eliminating Kickbacks in Recovery Act of 2018, and the 21st Century Cures 2.0 Concept Paper.

LobbyistCovered position, as disclosed
KRISTINE BLACKWOOD —
CASEY BROUHARD —
CJ MAHLER —
PARI MODY —
EUGENIA PIERSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 3404 (116th), H.R. 6102 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.